Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Readmission for COPD Exacerbation Upped In-hospital Mortality Risk

Key clinical point: Readmission within 30 days of hospitalization for an acute exacerbation of COPD was linked to a fourfold increase in mortality and a considerable health care economic burden.

Major finding: In-hospital mortality rate increased from 1.1% to 3.8% during readmission, with hospital costs of $0.97 billion and charges of $4.0 billion.

Study details: Retrospective cohort study including 530,229 adult patients in the 2016 National Readmission Database.

Disclosures: Study authors reported no relevant relationships.

Citation:

Krishnan AM et al. CHEST 2019. Abstract, doi: 10.1016/j.chest.2019.08.229.